Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Edema D004487 152 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Xiao J et al. Synergetic protective effects of combined blockade by two kinds of autolesion mediator receptor on neurological function after cervical cord injury. 1998 Chin. Med. J. pmid:10374355
Rosenbaum JT et al. Intravitreally injected platelet activating factor induces retinitis in experimental animals. 1999 Curr. Eye Res. pmid:10372995
Diaz E et al. Presence of platelet-activating factor in rhesus (Macaca mulatta) spermatozoa. 1999 J. Med. Primatol. pmid:10372538
Cahana A and Reiner O LIS1 and platelet-activating factor acetylhydrolase (Ib) catalytic subunits, expression in the mouse oocyte and zygote. 1999 FEBS Lett. pmid:10371146
Martínez L et al. Nitroprusside stimulates contractility and the synthesis of 14C-acetylated PAF-like substances in estrogen primed-mouse uterine horns. 1999 Prostaglandins Other Lipid Mediat. pmid:10367296
Steil AA et al. Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice. 1999 Prostaglandins Other Lipid Mediat. pmid:10367295
Goldman R et al. Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line. 1999 Biochim. Biophys. Acta pmid:10366777
Crawford SE et al. Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. 1999 J. Heart Lung Transplant. pmid:10363692
Del Sorbo L et al. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat. 1999 Eur. J. Immunol. pmid:10359105
Weber C et al. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions. 1999 Clin. Chem. Lab. Med. pmid:10353467
Svetlov SI et al. Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome. 1999 Pediatr. Nephrol. pmid:10353406
Cruzado JM et al. Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function. 1999 May-Jun Exp. Nephrol. pmid:10352362
Rainsford KD Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice. 1999 J. Pharm. Pharmacol. pmid:10344635
Mariano F et al. Production of platelet-activating factor in patients with sepsis-associated acute renal failure. 1999 Nephrol. Dial. Transplant. pmid:10344354
Cepinskas G et al. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. 1999 J. Cell. Sci. pmid:10341212
Nasu K et al. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. 1999 Mol. Hum. Reprod. pmid:10341002
McNulty CA et al. Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10340944
Yoshimura T et al. Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women. 1999 Maturitas pmid:10340285
Aliberti JC et al. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. 1999 Infect. Immun. pmid:10338485
Alvi SA et al. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. 1999 Mol. Hum. Reprod. pmid:10338371